Investing

Rocket Lab Tumbles on Yet Another Neutron Delay. Time to Bail?

Rocket Lab just pushed its biggest growth engine into 2027 while posting record revenue, leaving investors to decide whether the selloff is a buying opportunity or a warning sign they cannot afford to ignore.

By Rich Duprey
Published October 16, 2026, 7:26am ET · 3 min read

A powerful rocket launches against a dark background, with a bright orange flame at its base and a long, light blue exhaust plume extending upwards and to the left. Several smaller, glowing orange and white objects appear near the exhaust plume, possibly representing jettisoned stages or debris. To the right, a large, dense cloud of white and gray smoke fills the frame, likely from the launchpad.
A powerful rocket launch illustrates the high stakes and complex engineering involved in space exploration, reflecting the development challenges faced by companies like Rocket Lab with its Neutron project. © NASA / Ken Thornsley / Wikimedia Commons

Rocket Lab (NASDAQ:RKLB | RKLB Price Prediction) trades at $55.25 after the company pushed Neutron’s first launch into 2027, a 6.6% decline, though it had been down as much as 16% early on. The slip puts a question mark over the timing of the company’s largest growth engine just as its existing businesses post record results.

RKLB price target

Rocket Lab flies the Electron and HASTE rockets, builds satellites and spacecraft components, and is developing Neutron, a reusable medium-lift rocket. Chief Executive Peter Beck cited voids in the carbon-composite forward propellant dome, with replacement and testing now running through Q1 2027. Shares fell 11.86% in the latest session. That extended a six-session losing streak.

A Record $2.36 Billion Backlog Keeps Growing While Neutron Waits

Q2 revenue reached $234.07 million, up 62% year over year, the fourth straight quarter beating revenue estimates. Non-GAAP gross margin expanded to 41.5% from 36.9%, and the adjusted EBITDA loss narrowed to $8.8 million from $27.6 million.

Backlog rose 137% to $2.36 billion, driven by an $816 million Space Development Agency award and a role in Golden Dome. Management said it has had “absolutely zero issues” selling full-price Neutrons before a test flight. Cantor kept an Overweight rating with a $122 target.

RKLB earnings explorer

Every Neutron Slip Pushes Cash Flow Further Out

The CFO tied the cash-flow turning point to Neutron’s first successful launch, followed by 18 to 24 months of fleet investment before standalone cash-flow positivity. Clear Street cut its target to $105 from $129, saying the slip pushes growth and profitability out by three quarters. TD Cowen cut to $90 from $120.

Free cash flow was -$321.8 million in 2025, and the company raised $1.53 billion through stock sales in the first half of 2026. The 2026 EPS estimate of -$0.2682 drew five down revisions against one up revision over 30 days, while the Iridium Communications (NASDAQ:IRDM) deal adds integration risk through a mid-2027 close.

Space Systems Revenue Buys Time for the Dome Fix

Space Systems revenue hit $189.5 million last quarter, so operations keep growing without Neutron. The selloff also looks company-specific: AST SpaceMobile (NASDAQ:ASTS) jumped 5.5%. Still, conviction requires proof that the dome fix stays on schedule. Third-quarter revenue guidance of $250 million to $265 million is the next test.

Shares Trail the S&P 500 by a Wide Margin

At $55.25, the stock sits below a consensus target of $105.05, meaning roughly 90% upside. Targets offer a single view, and that figure may not fully reflect this week’s cuts. Ratings from 20 analysts break down as:

  • Strong Buy: 4
  • Buy: 12
  • Hold: 4
  • Sell: 0
RKLB analyst ratings

Rocket Lab is down 20.69% year-to-date, versus a 13.13% gain for the S&P 500. Over one week, the stock lost 18.88% while the index slipped 0.27%. Shares trade below the 200-day average of $81.49. With trailing EPS at -$0.27, there is no meaningful P/E.

RKLB price scenario

Neutron Hardware Tests Will Decide Rocket Lab’s Next Move

At $55.25, Rocket Lab’s path depends on Neutron milestones.

A bullish case needs completed dome requalification by Q1 2027 and fully fueled stage testing on the pad, which Beck called the milestone that “gets your adrenaline running.” A bearish case would follow a further slip beyond early 2027, fresh equity raises, or stalling backlog.

The steep one-week drop came while revenue grew above 60%. Neutron’s timeline started in mid-2025 and has kept moving. Over the next two earnings reports, keep an eye on revenue against guidance, cash burn, Neutron test updates, and Iridium approvals.

The next two quarters will show whether Neutron’s timeline is credible or still drifting.

Contact [email protected] for any questions or corrections.

Rich Duprey

After two decades of patrolling the dark corners of suburbia as a police officer, Rich Duprey hung up his badge and gun to begin writing full time about stocks and investing. For the past 20 years, he’s been cruising the markets looking for companies to lock up as long-term holdings in a portfolio while writing extensively on the broad sectors of consumer goods, technology, and industrials. Because his experience isn’t from the typical financial analyst track, Rich is able to break down complex topics into understandable and useful action points for the average investor. His writings have appeared on The Motley Fool, InvestorPlace, Yahoo! Finance, Money Morning, and, of course, 24/7 Wall St. He has been featured in both U.S. and international publications, including MarketWatch, Financial Times, Forbes, Fast Company, and USA Today.

All articles →